Clinical Trial Detail

NCT ID NCT03341143
Title Fecal Microbiota Transplant (FMT) in Melanoma Patients
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Zarour, Hassane, MD
Indications

melanoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.